logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5632.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5632.produseast1
Showing 1 - 3 of 3 Items
Showing 1 - 3 of 3 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

The use of Ebola convalescent plasma to treat Ebola Virus Disease in resource constrained settings: a perspective from the field

van Griensven J, De Weiggheleire A, Delamou A, Smith PJ, Edwards T,  et al.
2015-08-10 • Clinical Infectious Diseases
2015-08-10 • Clinical Infectious Diseases
The clinical evaluation of convalescent plasma (CP) for the treatment of Ebola Virus Disease (EVD) in the current outbreak, predominantly affecting Guinea, Sierra Leone and Liberia, was ...
Journal Article
|
Research

Electrolyte and metabolic disturbances in Ebola patients during a clinical trial, Guinea, 2015

van Griensven J, Bah EI, Haba N, Delamou A, Camara BS,  et al.
2016-12-01 • Emerging Infectious Diseases
2016-12-01 • Emerging Infectious Diseases
By using data from a 2015 clinical trial on Ebola convalescent-phase plasma in Guinea, we assessed the prevalence of electrolyte and metabolic abnormalities at admission and their predic...
Journal Article
|
Research

Evaluation of convalescent plasma for Ebola Virus Disease in Guinea

van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P,  et al.
2016-01-07 • New England Journal of Medicine
2016-01-07 • New England Journal of Medicine
BACKGROUND
In the wake of the recent outbreak of Ebola virus disease (EVD) in several African countries, the World Health Organization prioritized the evaluation of treatment with co...